A Post-Approval Study of the LINX® Reflux Management System

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DEVICE

LINX device

Trial Locations (19)

15224

Allegheny Western Pennsylvania Hospital, Pittsburgh

22205

Virginia Hospital Center, Arlington

30309

Esophageal Institute of Atlanta, PC., Atlanta

31406

Candler Hospital, Savannah

31701

Albany Surgical, Albany

43050

Knox Community Hospital, Mount Vernon

43210

Ohio State University Wexner Medical Center, Columbus

44106

University Hospitals Cleveland Medical Center - Geauga, Cleveland

53226

Froedtert and Medical College of Wisconsin, Milwaukee

54601

Gundersen Lutheran Medical Center, La Crosse

56441

Cuyuna Regional Medical Center, Crosby

80110

Swedish Medical Center/SurgOne, Englewood

83221

Bingham Memorial Hospital, Blackfoot

89113

VIP Surg PLLC, Las Vegas

90033

Keck Medical Center of Univeristy of Southern California, Los Angeles

92103

University of California San Diego, San Diego

97213

The Oregon Clinic, Portland

98104

Swedish Medical Center, Seattle

02215

Beth Israel, Boston

All Listed Sponsors
lead

Torax Medical Incorporated

INDUSTRY

NCT01940185 - A Post-Approval Study of the LINX® Reflux Management System | Biotech Hunter | Biotech Hunter